Phase II pilot study of induction erlotinib therapy in patients with resectable non-small cell lung cancer to select postoperative adjuvant therapy

被引：0
|
作者：
Lee, Dae Ho
Hong, Yong Sang
Kim, Tae Won
Jung, Kyung Hae
Kim, Sang -We
Suh, Cheolwon
Lee, Jung -Shin
Kim, Heung Tae
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2009年 / 8卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-09-C41
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C41
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Biweekly administration of docetaxel and gemcitabine as adjuvant therapy for stage II and IIIA non-small cell lung cancer: A phase II study
    Syrigos, Konstantinos N.
    Konstantinou, Marios
    Sepsas, Evangellos
    Papamichales, George
    Loullias, Achilleas
    Belenis, Ionas
    Skottis, Ionas
    Charpidou, Andriani
    Roussos, Charalambos
    ANTICANCER RESEARCH, 2007, 27 (4C) : 2887 - 2892
  • [42] Preoperative induction therapy in non-small cell lung cancer
    Goldstraw, P
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 625 - 631
  • [43] Induction therapy for non-small cell lung cancer (NSCLC)
    Nakamura, H
    Furukawa, K
    Ikeda, N
    Shibuya, H
    Tanaka, K
    Okunaka, T
    Hirano, T
    Sakai, M
    Saito, M
    Konaka, C
    Kato, H
    XXX WORLD CONGRESS OF THE INTERNATIONAL COLLEGE OF SURGEONS, VOLS 1-2, 1996, : 1029 - 1033
  • [44] PHASE II TRIAL OF ERLOTINIB IN PREVIOUSLY TREATED PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Okano, Yoshio
    Shinohara, Tsutomu
    Machida, Hisanori
    Hatakeyama, Nobuo
    Takeuchi, Eiji
    Doi, Hiroyuki
    Kubota, Tetsuya
    Yokoyama, Akihito
    Ogushi, Fumitaka
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1175 - S1176
  • [45] Phase II Study of Erlotinib with Concurrent Whole-brain Radiation Therapy for Patients with Brain Metastases from Non-small Cell Lung Cancer
    Welsh, J. W.
    Kim, E.
    Amini, A.
    Allen, P.
    Chang, J.
    Komaki, R.
    Nguyen, N.
    Holt, J.
    Erdman, D.
    Stea, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S136 - S136
  • [46] PHASE II STUDY OF ERLOTINIB WITH CONCURRENT WHOLE-BRAIN RADIATION THERAPY FOR PATIENTS WITH BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER
    Welsh, James
    Amini, Arya
    Kim, Edward
    Allen, Pamela K.
    Chang, Joe Y.
    Garland, Linda
    Komaki, Ritsuko
    Stea, Baldassarre
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1587 - S1587
  • [47] A phase II study of combination epigenetic therapy in advanced non-small cell lung cancer
    Juergens, Rosalyn
    Vendetti, Frank
    Wrangle, John
    Coleman, Barbara
    Sebree, Rosa
    Rudek-Renaut, Michelle
    Belinsky, Steven
    Brock, Malcolm
    Herman, James
    Baylin, Stephen
    Rudin, Charles
    CANCER RESEARCH, 2011, 71
  • [48] Phase II study of erlotinib in advanced non-small cell lung cancer patients with leptomeningeal metastasis.
    Nosaki, Kaname
    Shiraishi, Yoshimasa
    Hirai, Fumihiko
    Harada, Taishi
    Himeji, Daisuke
    Kitazaki, Takeshi
    Ebi, Noriyuki
    Hamada, Akinobu
    Yamanaka, Takeharu
    Takenoyama, Mitsuhiro
    Sugio, Kenji
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [49] Phase II study of erlotinib for acquired resistance to gefitinib in patients with advanced non-small cell lung cancer
    Horiike, A.
    Yamamoto, N.
    Tanaka, H.
    Yanagitani, N.
    Kudo, K.
    Ohyanagi, F.
    Naito, T.
    Murakami, H.
    Horai, T.
    Nishio, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [50] Phase II Study of Erlotinib for Acquired Resistance to Gefitinib in Patients with Advanced Non-small Cell Lung Cancer
    Horiike, Atsushi
    Yamamoto, Nobuyuki
    Tanaka, Hisashi
    Yanagitani, Noriko
    Kudo, Keita
    Ohyanagi, Fumiyoshi
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Horai, Takeshi
    Nishio, Makoto
    ANTICANCER RESEARCH, 2014, 34 (04) : 1975 - 1981
12345